Research Article

Macrophylloflavone: A New Biflavonoid from Garcinia macrophylla Mart. (Clusiaceae) for Antibacterial, Antioxidant, and Anti-Type 2 Diabetes Mellitus Activities

Table 2

Comparison of 13C-NMR spectra in 3-flavanone-6″-flavone of macrophylloflavone (1) with a number of biflavonoid 3-flavanone-8″-flavone.

CompoundPosition23456789101′2′3′4′5′6′

Macrophylloflavone (1)δC (ppm) (a)82.7250.84197.91164.8197.43165.7396.42168.19103.19130.49129.24115.61158.81115.54129.24
Morelloflavone (2) [44]δC (ppm) (b)81.0048.70195.60163.5096.20166.3095.20162.50101.50128.00128.10114.40157.10114.40128.10
Morelloflavone (2) [39]δC (ppm) (c)82.3050.10197.20163.5097.20162.4096.10164.20101.60129.80129.40115.50158.70115.50129.40
Morelloflavone (2) [40]δC (ppm) (d)81.0048.40196.30161.8095.40163.6096.30166.60101.60128.20128.60114.50157.40114.50128.60
Morelloflavone (2) [41]δC (ppm) (e)81.1048.10195.40163.3096.00166.1094.90162.40101.30127.80127.60114.30157.00114.30127.60
Morelloflavone (2) [42]δC (ppm) (f)81.5049.20196.50164.7096.30166.4095.20164.00102.10129.20128.40114.60157.50114.60128.40
Morelloflavone-4‴-O-β-D-glucoside (3) [30]δC (ppm) (g)82.6049.10198.00162.0098.10164.1097.60166.00102.80129.80128.60115.70158.70115.70128.60

CompoundPosition2″3″4″5″6″7″8″9″10″1‴2‴3‴4‴5‴6‴

Macrophylloflavone (1)δC (ppm) (a)165.73103.37183.83157.37102.02163.3199.83162.53104.95123.34114.17146.79150.94116.84120.55
Morelloflavone (2) [44]δC (ppm) (b)163.20102.40181.40160.3098.60161.40100.50155.00103.30121.20113.10145.40149.40116.10119.00
Morelloflavone (2) [39]δC (ppm) (c)164.20103.80183.10164.9099.60165.60103.90165.80103.00123.50114.20146.30150.00116.50120.70
Morelloflavone (2) [40]δC (ppm) (d)163.80102.30181.70160.6098.70162.90100.60155.30103.20121.10113.40145.70149.80116.20119.40
Morelloflavone (2) [41]δC (ppm) (e)163.30102.60181.00160.1098.30161.5099.30154.80102.60121.30113.30145.30149.20115.60118.40
Morelloflavone (2) [42]δC (ppm) (f)163.40102.90182.30164.7098.70161.70104.00155.90100.80122.60113.30145.50149.30115.80119.60
Morelloflavone-4‴-O-β-D-glucoside (3) [30]δC (ppm) (g)170.60104.10183.50158.3098.20161.10103.90153.30104.60120.50114.60145.40148.70117.20121.00

Solvent and magnetic field strength for (a) CD3OD, 125 MHz; (b) DMSO-d6, 22.64 MHz; (c) DMSO-d6, 25.10 MHz; (d) DMSO-d6; (e) DMSO-d6; (f) CDCl3; and (g) DMSO-d6, 100 MHz.